Trial Details
TERMINATEDBasic Information
| Clinical ID | c2446 |
|---|---|
| Identifier | NCT03472690 |
| Trial Title | QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | BIOLOGICAL: QBECO-SSI|OTHER: Placebo |
Participant Information
| Sponsor | Qu Biologics Inc. |
|---|---|
| City | British Columbia |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-06-25 |
|---|---|
| Primary Completion Date | 2020-12-20 |
| Completion Date | 2021-02-25 |